Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

Abroad (travel likely)RecruitingPHASE2

Conditions

Non-Muscle Invasive Bladder Urothelial Carcinoma · Recurrent Non-Muscle Invasive Bladder Urothelial Carcinoma · Stage I Bladder Cancer AJCC v8

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Highlands Oncology Group - Fayetteville, Fayetteville, Arkansas, United States

    Contact: Study coordinator (Site Public Contact) · research@hogonc.com · 479-872-8100
    Contact: Principal Investigator (Joseph T. Beck)
  • Highlands Oncology Group - Rogers, Rogers, Arkansas, United States

    Contact: Study coordinator (Site Public Contact) · research@hogonc.com · 479-872-8130
    Contact: Principal Investigator (Joseph T. Beck)
  • Highlands Oncology Group, Springdale, Arkansas, United States

    Contact: Study coordinator (Site Public Contact) · research@hogonc.com · 479-872-8130
    Contact: Principal Investigator (Joseph T. Beck)
  • AIS Cancer Center at San Joaquin Community Hospital, Bakersfield, California, United States

    Contact: Study coordinator (Site Public Contact) · 661-323-4673
    Contact: Principal Investigator (Luis Mariscal)
  • Los Angeles General Medical Center, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · uscnorrisinfo@med.usc.edu · 323-865-0451
    Contact: Principal Investigator (Lauren A. Lukas)
  • USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · 323-865-0451
    Contact: Principal Investigator (Lauren A. Lukas)
  • Shaw Cancer Center, Edwards, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 970-569-7429
    Contact: Principal Investigator (Erin Schwab)
  • Helen F Graham Cancer Center, Newark, Delaware, United States

    Contact: Study coordinator (Site Public Contact) · lbarone@christianacare.org · 302-623-4450
    Contact: Principal Investigator (Gregory A. Masters)
  • Medical Oncology Hematology Consultants PA, Newark, Delaware, United States

    Contact: Study coordinator (Site Public Contact) · lbarone@christianacare.org · 302-623-4450
    Contact: Principal Investigator (Gregory A. Masters)
  • UF Health Cancer Institute - Gainesville, Gainesville, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 352-273-8010
    Contact: Principal Investigator (Daniel V. Araujo)
  • Mount Sinai Medical Center, Miami Beach, Florida, United States

    Contact: Study coordinator (Site Public Contact) · Yvonne.Enriquez@msmc.com · 305-674-2625
    Contact: Principal Investigator (Bruno R. Bastos)
  • Grady Health System, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · 404-778-1868
    Contact: Principal Investigator (Kamran Salari)
  • Emory Proton Therapy Center, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · allyson.anderson@emory.edu · 404-251-2854
    Contact: Principal Investigator (Kamran Salari)
  • Emory University Hospital Midtown, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · 888-946-7447
    Contact: Principal Investigator (Kamran Salari)
  • Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · 404-778-1868
    Contact: Principal Investigator (Kamran Salari)
  • Emory Saint Joseph's Hospital, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · 404-851-7115
    Contact: Principal Investigator (Kamran Salari)
  • Rush MD Anderson Cancer Center, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Cancer_Studies@rush.edu · 312-226-2371
    Contact: Principal Investigator (Dian Wang)
  • Carle at The Riverfront, Danville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@Carle.com · 800-446-5532
    Contact: Principal Investigator (Daniel H. Barnett)
  • Cancer Care Specialists of Illinois - Decatur, Decatur, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Decatur Memorial Hospital, Decatur, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Carle Physician Group-Effingham, Effingham, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Daniel H. Barnett)
  • Crossroads Cancer Center, Effingham, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Daniel H. Barnett)
  • Carle BroMenn Medical Center, Normal, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@Carle.com · 800-446-5532
    Contact: Principal Investigator (Daniel H. Barnett)
  • Carle Cancer Institute Normal, Normal, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@Carle.com · 800-446-5532
    Contact: Principal Investigator (Daniel H. Barnett)
  • HSHS Saint Elizabeth's Hospital, O'Fallon, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Southern Illinois University School of Medicine, Springfield, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 217-545-7929
    Contact: Principal Investigator (Bryan A. Faller)
  • Springfield Clinic, Springfield, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 800-444-7541
    Contact: Principal Investigator (Bryan A. Faller)
  • Springfield Memorial Hospital, Springfield, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · pallante.beth@mhsil.com · 217-528-7541
    Contact: Principal Investigator (Bryan A. Faller)
  • Carle Cancer Center, Urbana, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Daniel H. Barnett)
  • Mary Greeley Medical Center, Ames, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-956-4132
    Contact: Principal Investigator (Joseph J. Merchant)
  • McFarland Clinic - Ames, Ames, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · ksoder@mcfarlandclinic.com · 515-239-4734
    Contact: Principal Investigator (Joseph J. Merchant)
  • UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Mercy Cancer Center-West Lakes, Clive, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Richard L. Deming)
  • UI Health Care Mission Cancer and Blood - West Des Moines Clinic, Clive, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Iowa Methodist Medical Center, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-6727
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Broadlawns Medical Center, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-282-2200
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Mercy Medical Center - Des Moines, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Richard L. Deming)
  • UI Health Care Mission Cancer and Blood - Laurel Clinic, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • UI Healthcare Mission Cancer and Blood - Pella, Pella, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · trials@missioncancer.com · 515-282-2921
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • UI Health Care Mission Cancer and Blood - Waukee Clinic, Waukee, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • The Iowa Clinic PC, West Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-875-9815
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • University of Kansas Cancer Center, Kansas City, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · KUCC_Navigation@kumc.edu · 913-588-3671
    Contact: Principal Investigator (Eugene K. Lee)
  • University of Kansas Cancer Center-Overland Park, Overland Park, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · KUCC_Navigation@kumc.edu · 913-588-3671
    Contact: Principal Investigator (Eugene K. Lee)
  • University of Kansas Hospital-Indian Creek Campus, Overland Park, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · KUCC_Navigation@kumc.edu · 913-588-3671
    Contact: Principal Investigator (Eugene K. Lee)
  • University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · KUCC_Navigation@kumc.edu · 913-588-3671
    Contact: Principal Investigator (Eugene K. Lee)
  • Louisiana Hematology Oncology Associates LLC, Baton Rouge, Louisiana, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@marybird.com · 225-215-1353
    Contact: Principal Investigator (Scott E. Delacroix)
  • Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@marybird.com · 225-215-1353
    Contact: Principal Investigator (Scott E. Delacroix)
  • Mary Bird Perkins Cancer Center - Gonzales, Gonzales, Louisiana, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@marybird.com · 225-215-1353
    Contact: Principal Investigator (Scott E. Delacroix)
  • Mary Bird Perkins Cancer Center - Metairie, Metairie, Louisiana, United States

    Contact: Study coordinator (Site Public Contact) · 504-584-6990
    Contact: Principal Investigator (Scott E. Delacroix)
  • Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · 877-726-5130
    Contact: Principal Investigator (Sophia C. Kamran)
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Samir Narayan)
  • Trinity Health Medical Center - Brighton, Brighton, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Samir Narayan)
  • Trinity Health Medical Center - Canton, Canton, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Samir Narayan)
  • Chelsea Hospital, Chelsea, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Samir Narayan)
  • University of Michigan Health - Sparrow Lansing, Lansing, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · harsha.trivedi@umhsparrow.org · 517-364-3712
    Contact: Principal Investigator (Samir Narayan)
  • Trinity Health Saint Mary Mercy Livonia Hospital, Livonia, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Samir Narayan)
  • Michigan Healthcare Professionals Pontiac, Pontiac, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · Emily.Crofts@trinity-health.org · 248-858-6215
    Contact: Principal Investigator (Samir Narayan)
  • Trinity Health Saint Joseph Mercy Oakland Hospital, Pontiac, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Samir Narayan)
  • Sanford Joe Lueken Cancer Center, Bemidji, Minnesota, United States

  • Essentia Health Saint Joseph's Medical Center, Brainerd, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Essentia Health - Deer River Clinic, Deer River, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Essentia Health Cancer Center, Duluth, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Essentia Health Saint Mary's Medical Center, Duluth, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Miller-Dwan Hospital, Duluth, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Essentia Health Hibbing Clinic, Hibbing, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Essentia Health Sandstone, Sandstone, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Essentia Health Virginia Clinic, Virginia, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Saint Francis Medical Center, Cape Girardeau, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · sfmc@sfmc.net · 573-334-2230
    Contact: Principal Investigator (Bryan A. Faller)
  • Parkland Health Center - Farmington, Farmington, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-996-5569
    Contact: Principal Investigator (Bryan A. Faller)
  • University of Kansas Cancer Center - Briarcliff, Kansas City, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 913-588-3671
    Contact: Principal Investigator (Eugene K. Lee)
  • University of Kansas Cancer Center - North, Kansas City, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · KUCC_Navigation@kumc.edu · 913-588-3671
    Contact: Principal Investigator (Eugene K. Lee)
  • University of Kansas Cancer Center - Lee's Summit, Lee's Summit, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · KUCC_Navigation@kumc.edu · 913-588-3671
    Contact: Principal Investigator (Eugene K. Lee)
  • Lake Regional Hospital, Osage Beach, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · clinicaltrials@lakeregional.com · 573-302-2768
    Contact: Principal Investigator (Jay W. Carlson)
  • Sainte Genevieve County Memorial Hospital, Sainte Genevieve, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-996-5569
    Contact: Principal Investigator (Bryan A. Faller)
  • Mercy Hospital South, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · Danielle.Werle@mercy.net · 314-525-6042
    Contact: Principal Investigator (Jay W. Carlson)
  • Missouri Baptist Medical Center, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-996-5569
    Contact: Principal Investigator (Bryan A. Faller)
  • Mercy Hospital Saint Louis, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-251-7066
    Contact: Principal Investigator (Jay W. Carlson)
  • Missouri Baptist Sullivan Hospital, Sullivan, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-996-5569
    Contact: Principal Investigator (Bryan A. Faller)
  • BJC Outpatient Center at Sunset Hills, Sunset Hills, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-996-5569
    Contact: Principal Investigator (Bryan A. Faller)
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Justin M. Haseltine)
  • Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Justin M. Haseltine)
  • Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Justin M. Haseltine)
  • Memorial Sloan Kettering Commack, Commack, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Justin M. Haseltine)
  • Memorial Sloan Kettering Westchester, Harrison, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Justin M. Haseltine)
  • Memorial Sloan Kettering Cancer Center, New York, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Justin M. Haseltine)
  • Memorial Sloan Kettering Nassau, Uniondale, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Justin M. Haseltine)
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@med.unc.edu · 877-668-0683
    Contact: Principal Investigator (Mary E. Westerman)
  • Sanford Broadway Medical Center, Fargo, North Dakota, United States

  • Sanford Roger Maris Cancer Center, Fargo, North Dakota, United States

  • Riverside Methodist Hospital, Columbus, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jennifer.Sexton@ohiohealth.com · 614-788-3860
    Contact: Principal Investigator (Michael Siedow)
  • Grant Medical Center, Columbus, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jennifer.Sexton@ohiohealth.com · 614-788-3860
    Contact: Principal Investigator (Michael Siedow)
  • Doctors Hospital, Columbus, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jennifer.Sexton@ohiohealth.com · 614-788-3860
    Contact: Principal Investigator (Michael Siedow)
  • Dublin Methodist Hospital, Dublin, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jennifer.Sexton@ohiohealth.com · 614-788-3860
    Contact: Principal Investigator (Michael Siedow)
  • OhioHealth Mansfield Hospital, Mansfield, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jennifer.Sexton@ohiohealth.com · 614-788-3860
    Contact: Principal Investigator (Michael Siedow)
  • OhioHealth Marion General Hospital, Marion, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jennifer.Sexton@ohiohealth.com · 614-788-3860
    Contact: Principal Investigator (Michael Siedow)
  • University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States

    Contact: Study coordinator (Site Public Contact) · ou-clinical-trials@ouhsc.edu · 405-271-8777
    Contact: Principal Investigator (Tyler Gunter)
  • Christiana Care Health System-Concord Health Center, Chadds Ford, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · lbarone@christianacare.org · 302-623-4450
    Contact: Principal Investigator (Gregory A. Masters)
  • Geisinger Medical Center, Danville, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · HemonCCTrials@geisinger.edu · 570-271-5251
    Contact: Principal Investigator (Heath B. Mackley)
  • Geisinger Cancer Center Dickson City, Dickson City, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · hemoncctrials@geisinger.edu · 877-204-6081
    Contact: Principal Investigator (Heath B. Mackley)
  • UPMC Hillman Cancer Center Erie, Erie, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ClinicalResearchServices@upmc.edu · 412-864-7716
    Contact: Principal Investigator (Adam Olson)
  • UPMC Cancer Center at UPMC Horizon, Farrell, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · Roster@nrgoncology.org · 412-339-5294
    Contact: Principal Investigator (Adam Olson)
  • UPMC Cancer Centers - Arnold Palmer Pavilion, Greensburg, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 724-838-1900
    Contact: Principal Investigator (Adam Olson)
  • Penn State Milton S Hershey Medical Center, Hershey, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · CTO@hmc.psu.edu · 717-531-3779
    Contact: Principal Investigator (Hyma Polimera)
  • Geisinger Medical Oncology-Lewisburg, Lewisburg, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · HemonCCTrials@geisinger.edu · 570-374-8555
    Contact: Principal Investigator (Heath B. Mackley)
  • UPMC Cancer Center - Monroeville, Monroeville, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · Roster@nrgoncology.org · 412-339-5294
    Contact: Principal Investigator (Adam Olson)
  • UPMC Hillman Cancer Center - Monroeville, Monroeville, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ClinicalResearchServices@upmc.edu · 412-864-7716
    Contact: Principal Investigator (Adam Olson)
  • UPMC Hillman Cancer Center - New Castle, New Castle, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · haneydl@upmc.edu · 412-389-5208
    Contact: Principal Investigator (Adam Olson)
  • UPMC-Magee Womens Hospital, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-647-2811
    Contact: Principal Investigator (Adam Olson)
  • UPMC-Saint Margaret, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-784-4900
    Contact: Principal Investigator (Adam Olson)
  • University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-647-8073
    Contact: Principal Investigator (Adam Olson)
  • UPMC-Shadyside Hospital, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-621-2334
    Contact: Principal Investigator (Adam Olson)
  • UPMC-Passavant Hospital, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-367-6454
    Contact: Principal Investigator (Adam Olson)
  • UPMC Cancer Center at UPMC Northwest, Seneca, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 814-676-7900
    Contact: Principal Investigator (Adam Olson)
  • UPMC Cancer Center-Washington, Washington, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · Roster@nrgoncology.org · 412-339-5294
    Contact: Principal Investigator (Adam Olson)
  • UPMC Washington Hospital Radiation Oncology, Washington, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · cancer@washingtonhospital.org · 724-223-3788
    Contact: Principal Investigator (Adam Olson)
  • Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · HemonCCTrials@geisinger.edu · 570-271-5251
    Contact: Principal Investigator (Heath B. Mackley)
  • Central Vermont Medical Center/National Life Cancer Treatment, Berlin Corners, Vermont, United States

    Contact: Study coordinator (Site Public Contact) · 802-225-5400
    Contact: Principal Investigator (Alexander P. Lukez)
  • University of Vermont Medical Center, Burlington, Vermont, United States

    Contact: Study coordinator (Site Public Contact) · rpo@uvm.edu · 802-656-4101
    Contact: Principal Investigator (Alexander P. Lukez)
  • University of Vermont and State Agricultural College, Burlington, Vermont, United States

    Contact: Study coordinator (Site Public Contact) · rpo@uvm.edu · 802-656-8990
    Contact: Principal Investigator (Alexander P. Lukez)
  • University of Virginia Cancer Center, Charlottesville, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · uvacancertrials@hscmail.mcc.virginia.edu · 434-243-6303
    Contact: Principal Investigator (Christopher Luminais)
  • Bon Secours Memorial Regional Medical Center, Mechanicsville, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · anne_carmellat@bshsi.org · 804-893-8978
    Contact: Principal Investigator (Joseph D. Pennington)
  • Bon Secours Saint Francis Medical Center, Midlothian, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · anne_carmellat@bshsi.org · 804-893-8978
    Contact: Principal Investigator (Joseph D. Pennington)
  • Bon Secours Saint Mary's Hospital, Richmond, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · anne_carmellat@bshsi.org · 804-893-8978
    Contact: Principal Investigator (Joseph D. Pennington)
  • Bon Secours Cancer Institute at Reynolds Crossing, Richmond, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · Anne_caramella@bshsi.org · 804-893-8978
    Contact: Principal Investigator (Joseph D. Pennington)
  • VCU Massey Comprehensive Cancer Center, Richmond, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · CTOclinops@vcu.edu · 804-628-6430
    Contact: Principal Investigator (Alfredo I. Urdaneta)
  • VCU Community Memorial Health Center, South Hill, Virginia, United States

  • West Virginia University Healthcare, Morgantown, West Virginia, United States

    Contact: Study coordinator (Site Public Contact) · cancertrialsinfo@hsc.wvu.edu · 304-293-7374
    Contact: Principal Investigator (Joanna A. Kolodney)
  • Duluth Clinic Ashland, Ashland, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Northwest Wisconsin Cancer Center, Ashland, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Marshfield Medical Center - Weston, Weston, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Bevan Ly)
  • The Research Institute of the McGill University Health Centre (MUHC), Montreal, Quebec, Canada

    Contact: Study coordinator (Site Public Contact) · evelyn.ortega@muhc.mcgill.ca · 514-934-1934
    Contact: Principal Investigator (Fabio L. Cury)
  • CHU de Quebec-L'Hotel-Dieu de Quebec (HDQ), Québec, Quebec, Canada

    Contact: Study coordinator (Site Public Contact) · rechclinique@crchuq.ulaval.ca
    Contact: Principal Investigator (Eric Vigneault)
Study leads
  • Brian C Baumann

    Principal Investigator

    NRG Oncology